Administrative Supplements for Dissemination of Cancer-related Surveillance Research

Notice Number: NOT-CA-08-008

Key Dates
Release Date: January 14, 2008

Issued by
National Cancer Institute (NCI), (


The NCI is announcing the availability of administrative supplements for NCI-funded cancer control research. Current NCI awardees of R01, P01, P50, U01, and U19 grants pertinent to cancer control may apply for an administrative supplement provided the following conditions are met:

1) The topic area of the original cancer control award must be related to the focus of the surveillance research/surveillance data analysis that is being proposed in the supplement request (for example if the parent grant focuses on physical activity, the supplement should focus on the dissemination of surveillance data on physical activity);
2) The proposed surveillance dissemination effort must be clearly beyond the scope of the “parent” award;
3) The “parent” award must remain active during the entire funding period of this supplement; and
4) The Principal Investigator (PI) for the supplement must be the PI of the “parent” award.

Diverse aspects of cancer control might be appropriate for dissemination efforts under these supplements (e.g., cancer risk factors, screening, cancer rates, treatment, and outcomes).  Specific areas include, but are not limited to:

Projects proposed for supplemental funding should examine optimal ways to disseminate surveillance information to particular target audiences. Applicants should indicate how the availability and use of this information is expected to impact planning and/or policy decision making at the level of health care providers and/or other organizational levels (e.g., community-based and/or broader programs). 
Investigators applying for these supplements are strongly encouraged to establish appropriate collaborations with experts in dissemination and diffusion research and practice, and/or researchers/practitioners who can provide unique expertise related to the context of the intended dissemination & diffusion audience in the supplement application.

Investigators are encouraged to initiate interactions the intended dissemination and diffusion audience early in the development of the project. It is also recommended that applicants requesting supplemental funding have a “product” (i.e., the results of surveillance research/surveillance data, communication or data modeling tools) ready for dissemination (or at least pre-testing) once the supplemental funding commences. The funding preference is for dissemination research rather than extended generation of materials/data/communication tools to be disseminated.

Examples of previously awarded supplements are available at: of research objectives for the surveillance supplements include:

(1) testing strategies for applying surveillance data to problems in cancer-related policy, programs, and practice across the range of cancer control activities from prevention through survivorship;

(2) communications research to test different ways to “tell compelling stories” to decision-makers with surveillance research data; and

(3) improving strategies for the dissemination of surveillance research tools and data, including: (a) the development and evaluation of tools for communication and education to new audiences who may benefit from the knowledge of surveillance research tools and data; (b) the development of new methods for analyzing surveillance data to be directly applicable to developing policy, programs, and practice in specific communities, practice areas, or populations; (c) the development of data use tools or training venues for increasing the use of surveillance tools and data; and (d) developing and/or testing methods for educating communities on the use of surveillance research to improve cancer-related policy, programs, and practice in their communities.

Note: Priority in funding will be given to applications that include plans to disseminate surveillance research information concerning low income and ethnically diverse populations.

Submission of Requests

Requests for these administrative supplements must be submitted to DCCPS (see address below) as for a single receipt date of April 1, 2008. Note that the NIH Center for Scientific Review (CSR) IS NOT involved in receipt and processing of these requests.

Submit a signed, typewritten original of the request and five signed, single-sided photocopies, in one package to:

Emily Dowling
Division of Cancer Control and Population Sciences
National Cancer Institute
6130 Executive Boulevard, EPN Room 4111, MSC 0001
Bethesda, MD 20892-0001 (for U.S. Postal Service express or regular mail)
Rockville, MD 20852 (for non-USPS delivery)

Detailed submission instructions are provided in the Submission Guidelines ( Briefly, the request should contain sufficient detail (similar to a standard research application) to allow the NCI staff members to assess the scientific merit of the proposed surveillance research dissemination plans and the appropriateness of the request for supplemental funding.  Budget requests must not exceed $100,000 in total costs for a funding period not exceeding 12 months.
Requests will be evaluated by NCI program staff (and appropriate consultants) who have expertise in the cancer control surveillance research area and/or in research dissemination.  Awards will be determined on the basis of scientific merit, program relevance, dissemination research potential, and availability of funds.
The earliest anticipated award date for this program will be August 1, 2008.


Before submitting a request, each PI is encouraged to discuss their plans for supplemental research with the NCI Program Director (i.e., Program Official) who is responsible for the particular “parent” R01, P01, P50, U01, or U19 award.

General inquiries concerning the programmatic and review matters should be directed to:

Jon F. Kerner, Ph.D.
Deputy Director for Research Dissemination and Diffusion
Division of Cancer Control and Population Sciences
National Cancer Institute
6130 Executive Boulevard, EPN Room 6144, MSC 0001
Bethesda, MD 20892-0001 (for U.S. Postal Service express or regular mail)
Rockville, MD 20852 (for non-USPS  delivery)
Telephone: 301-594-7294

Inquiries regarding administrative and fiscal matters should be directed to:

Crystal Wolfrey
Office of Grants Administration
National Cancer Institute
6120 Executive Boulevard, EPS Room 243, MSC 7150
Bethesda, MD 20892-7150 (for U.S. Postal Service express or regular mail)
Rockville, MD 20852 (for non-USPS delivery)
Telephone: 301-496-8634

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices

Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS) - Government Made Easy

Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.